ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Akynzeo IV 235 mg / 0.25 mg, Konzentrat zur Herstellung einer Infusionslösung - 
68290001 Medius AG
Akynzeo IV 235 mg / 0.25 mg, Konzentrat zur Herstellung einer Infusionslösung01.09.2022
  01.09.2022
Palonosetron, Combinations (A04AA55) 
WHO-DDD31.08.2027
01.09. 
01.09. 
B  
Yes 
IP 
77.72Yes
    
10 %100.95
  
7680682900015Synthetika
  
Composition
fosnetupitantum 235 mg ut fosnetupitantum chloridum hydrochloridum corresp. netupitantum 197.5 mg, palonosetronum 0.25 mg ut palonosetroni hydrochloridum, dinatrii edetas, mannitolum, natrii hydroxidum q.s. ad pH, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 24.4 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Fosnetupitantum235 mg
Palonosetrone0.25 mg
BAG: Active AgentDose
Fosnetupitantum235 mg
Palonosetrone0.25 mg
 
Inactive agents
Dinatrii Edetas
Mannitol
Sodium Hydroxide
 
Source
Data was imported : 07.07.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home